CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 121 filers reported holding CARIBOU BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $455,902 | -13.7% | 79,564 | -28.0% | 0.33% | -19.0% |
| Q3 2023 | $528,305 | +17.5% | 110,524 | +4.4% | 0.41% | +37.6% |
| Q2 2023 | $449,760 | +0.3% | 105,826 | +25.3% | 0.30% | -6.3% |
| Q1 2023 | $448,520 | -5.0% | 84,467 | +12.5% | 0.32% | -19.6% |
| Q4 2022 | $472,000 | -35.5% | 75,107 | +8.3% | 0.39% | -36.8% |
| Q3 2022 | $732,000 | -46.6% | 69,376 | -72.5% | 0.62% | +96.8% |
| Q2 2022 | $1,370,000 | +200.4% | 252,272 | +407.9% | 0.32% | +2.3% |
| Q1 2022 | $456,000 | -15.1% | 49,674 | +39.6% | 0.31% | -15.2% |
| Q4 2021 | $537,000 | -31.5% | 35,592 | +8.4% | 0.36% | -32.9% |
| Q3 2021 | $784,000 | – | 32,836 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 72 Investment Holdings, LLC | 474,067 | $2,266,040 | 15.18% |
| Elmwood Wealth Management, Inc. | 2,364,415 | $11,301,904 | 5.45% |
| PFM Health Sciences, LP | 6,724,715 | $32,144,138 | 1.51% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 892,786 | $4,267,517 | 1.29% |
| Avidity Partners Management LP | 6,050,212 | $28,920,013 | 1.16% |
| Paradigm Biocapital Advisors LP | 2,944,513 | $14,074,772 | 0.96% |
| Kynam Capital Management, LP | 1,068,527 | $5,107,559 | 0.84% |
| Green Alpha Advisors, LLC | 110,524 | $528,305 | 0.41% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,500,000 | $16,730,000 | 0.37% |
| Bruce & Co., Inc. | 200,000 | $956,000 | 0.33% |